Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Glioblastoma and calcium signaling--analysis of calcium toolbox expression.

Robil N, Petel F, Kilhoffer MC, Haiech J.

Int J Dev Biol. 2015;59(7-9):407-15. doi: 10.1387/ijdb.150200jh.

2.

Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.

Callari M, Cappelletti V, D'Aiuto F, Musella V, Lembo A, Petel F, Karn T, Iwamoto T, Provero P, Daidone MG, Gianni L, Bianchini G.

Clin Cancer Res. 2016 Jan 15;22(2):337-45. doi: 10.1158/1078-0432.CCR-15-0757. Epub 2015 Sep 30.

3.

Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity.

Brambilla C, Laffaire J, Lantuejoul S, Moro-Sibilot D, Mignotte H, Arbib F, Toffart AC, Petel F, Hainaut P, Rousseaux S, Khochbin S, de Reyniès A, Brambilla E.

Clin Cancer Res. 2014 Nov 15;20(22):5777-86. doi: 10.1158/1078-0432.CCR-14-0459. Epub 2014 Sep 4.

4.

Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.

de Reyniès A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N, Galateau-Sallé F, Copin MC, Hofman P, Cazes A, Andujar P, Imbeaud S, Petel F, Pairon JC, Le Pimpec-Barthes F, Zucman-Rossi J, Jean D.

Clin Cancer Res. 2014 Mar 1;20(5):1323-34. doi: 10.1158/1078-0432.CCR-13-2429. Epub 2014 Jan 17.

5.

Identity by descent mapping of founder mutations in cancer using high-resolution tumor SNP data.

Letouzé E, Sow A, Petel F, Rosati R, Figueiredo BC, Burnichon N, Gimenez-Roqueplo AP, Lalli E, de Reyniès A.

PLoS One. 2012;7(5):e35897. doi: 10.1371/journal.pone.0035897. Epub 2012 May 2.

6.

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Missiaglia E, Williamson D, Chisholm J, Wirapati P, Pierron G, Petel F, Concordet JP, Thway K, Oberlin O, Pritchard-Jones K, Delattre O, Delorenzi M, Shipley J.

J Clin Oncol. 2012 May 10;30(14):1670-7. doi: 10.1200/JCO.2011.38.5591. Epub 2012 Mar 26.

PMID:
22454413
7.

Comparison of the latest commercial short and long oligonucleotide microarray technologies.

de Reyniès A, Geromin D, Cayuela JM, Petel F, Dessen P, Sigaux F, Rickman DS.

BMC Genomics. 2006 Mar 15;7:51.

8.

[Unsuccessful surgery of Cushing's disease. Role and efficacy of fractionated stereotactic radiotherapy].

Colin P, Delemer B, Nakib I, Caron J, Bazin A, Bernard MH, Peruzzi P, Scavarda D, Scherpereel B, Longuebray A, Redon C, Petel F, Rousseaux P.

Neurochirurgie. 2002 May;48(2-3 Pt 2):285-93. Review. French.

PMID:
12058133
9.

The protein-protein interaction map of Helicobacter pylori.

Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, Lenzen G, Petel F, Wojcik J, Schächter V, Chemama Y, Labigne A, Legrain P.

Nature. 2001 Jan 11;409(6817):211-5. Erratum in: Nature 2001 Feb 1;409(6820):553. Nature 2001 Feb 8;409(6821):743.

PMID:
11196647
10.

Supplemental Content

Support Center